Global Dialyzer Market Overview:
Dialyzer refers to an artificial filter containing fine fibers used for dialysis. The function of a dialyzer is to return the internal milieu to a more normal state through water removal and solute exchange between blood and dialysate. Dialyzer market has high growth prospects owing to rise in healthcare expenditure globally and technological advancement in the dialyzers. Further, the growing geriatric population, increasing number of patients with kidney diseases and favorable reimbursement policies expected to drive the demand for dialyzer over the forecasted period. According to AMA, the Global Dialyzer market is expected to see growth rate of 6.1%
- Increasing Number of End-Stage Renal Disease (ESRD) Patients
- Growth in Geriatric Population
- Technical Innovation in the Dialyzer
- Increasing Adoption of Dialysis for the Kidney Diseases
- Stringent Government Regulations Regarding Therapeutic Devices
- High Cost Associated With Dialysis
- Rising Demand of Hollow Fiber Dialyzers
- Increasing In Health Care Expenditure Globally
- Waste Disposal of Dialyzers Causing Adverse Effect on Environment
Number of players are present in the market hence fragmented nature of the market. Market players are focusing on technological developments. Further, increasing demand from the emerging economies expected to generate lucrative opportunities for the market players in the dialyzers market.
Some of the key players profiled in the report are Baxter (United States), Asahi Kasei Corporation (Japan), Cardinal Health (United States), Farmasol (Turkey), Cantel Medical Corporation (United States), TERUMO CORPORATION (Japan), Fresenius Medical Care (Germany), Becton Dickinson (United States), Allmed Medical Care Holdings Limited (United Kingdom), JMS Co., Ltd. (Japan) and NIPRO (India). Additionally, following companies can also be profiled that are part of our coverage like Browndove Healthcare (P) Ltd. (India), Bain Medical Equipment Co., Ltd. (China) and Kawasumi Laboratories Inc. (Japan). Analyst at AdvanceMarketAnalytics see United States, Japan Players to retain maximum share of Global Dialyzer market by 2023. Considering Market by Fluz Type, the sub-segment i.e. High Flux Dialyzers will boost the Dialyzer market. Considering Market by Material, the sub-segment i.e. Polysulfone Dialyzers will boost the Dialyzer market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Dialyzer market.
“According to the Food and Drug Administration, the conventional dialyzer allows a transfer of water and solutes between the blood and the dialysate through the semipermeable membrane. The semipermeable membrane of the conventional dialyzer has a sufficiently low permeability to water that an ultrafiltration controller is not required to prevent excessive loss of water from the patient's blood. This conventional dialyzer does not include hemodialyzers with the disposable inserts (Kiil type) or dialyzers of high permeability.”
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Dialyzer market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Dialyzer market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Dialyzer Manufacturer, Dialyzer Distributors, Potential Investors, Government and Other Regulatory Bodies, Research Institutes and Organizations, Market Research Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.